Dave Brown, Managing Director, Thomson Reuters IP Solutions, discusses the
2012 Top 100 Global Innovators program on Markets Now.
Watch the video>>
Fifteen years ago, it ranked among the most-cited topics in biomedicine. Now, programmed cell death, or apoptosis, has reached a point of "obliteration" —and that's a good thing for research.
Thomson Reuters study explores Apple’s mobile patent portfolio for insights into the new iPhone technology and litigation activity. Get a glimpse of battery-free future, insight into smartphone ‘patent wars’